LIPID PEROXIDATION AND ANTIOXIDANT ACTIVITY IN ORAL FLUID OF PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS: EFFECT OF PERIODONTAL TREATMENT

  • M. B. Khudiakova Kharkiv National Medical University, Kharkiv, Ukraine
Keywords: malondialdehyde, lipid peroxidation, superoxide dismutase, antioxidant activity, chronic generalized periodontitis, pathogenesis, lipoflavon.

Abstract

The research demonstrates pathogenetic role of abnormal processes of lipid peroxidation and antioxidant defense in the oral fluid in their connection with clinical change in development of chronic generalized periodontitis of initial-I degrees of severity. High therapeutic efficiency of the lipoflavon was shown to be determined by antioxidant, membranotropic, anti-inflammatory effects.

Downloads

Download data is not yet available.

References

1. Canakci CF, Canacki V, &Tatar A, et al. (2009). Increased levels of 8-hydroxyguanosine and malondialdehyde and its relationship with antioxidant enzymes in saliva of periodontitis patients. Eur J Dent, 3, 100-106.

2. Tsai CC, Chen HS, &Chen SC, et al. (2005). Lipid peroxidation: A possible role in the induction and progression of chronic periodontitis. J periodontal Res, 40(5), 378-384.

3. Chappel ILC, & Mathews JB. (2007). The role of reactive oxygen and antioxidant species in periodontal tissues destruction. Periodontol 2000, 43, 160-232.

4. Das K, Samanta L, & Chainy GBN. (2000). A modified spectophometric assay of superoxide dismutase using nitrite formation by superoxide radical. IJBB, 37, 201-204.

5. Barer, G. M., (2008). Terapevt`icheskaya stomatologi`ya. Chast`2. Bolezni parodonta. Moscow: GEOTAR. [in Russian].

6. Barer, G. M., Solov`eva, O. V., & Yanushevich` O. O. (2002). Sistemie lokal`noy dostavky lekarstv v lechenii parodontita. [The systems of local drug delivery in the treatment of periodontitis: a literature review]. Parodontologiya, 3 (24), 23-28.

7. Melnychuk, G. M., Rozhko, M. M., & Sawerbnaya L. B. (2011). Gingivit, parodontit, parodontoz: osobluvosty likuvan`ya [Gingivitis, periodontal diseases, parodontosis: features of treatment]. Ivano-Frankivsk. [in Ukrainian].

8. Danilevskiy, N. F., & Borisenko, A. I. (2000). Zabolevaniya parodonta [Periodontal diseases]. Kyiv: Health. [in Ukrainian].

9. Mash`enko, I. S. (2003). Bolezni parodonta [Periodontal diseases]. Drogobych: Colo. [in Ukrainian].

10. Grud`yanov, A. I, & Starikov, A. I. (1998). Lekarstvennie sredstva, primenya`emie pry zabolevaniy`ah parodonta. [Medical drugs which using in periodontal diseases]. Parodontologiya, 2, 6-17.

11. Goniotaki, M., Hatziantoniou, S., & Dimas, K., et al. (2004). Encapsulation of naturally flavonoids into liposomes: physicochemical properties and biological activity against human cancer cell lines. J. Pharm. Pharmacol., 56(10), 1217-1224.

12. Pragati, S, Ashok, S, & Kuldeep, S. (2009). Recent advances in periodontal drug delivery systems. Int J Drug Del, 1, 1-14.

13. Kuppusamy P, Shanmugam M, & Cinnamanoor RR. (2005). Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett, 10(2), 255-264.

14. Agnihotri R, Pandurang P, & Kamat SU. (2009). Association of cigarette smoking with superoxide dismutase enzyme levels in subjects with chronic periodontitis. J Periodontol, 80(4), 657-666.
Published
2018-03-21
How to Cite
Khudiakova, M. B. (2018). LIPID PEROXIDATION AND ANTIOXIDANT ACTIVITY IN ORAL FLUID OF PATIENTS WITH CHRONIC GENERALIZED PERIODONTITIS: EFFECT OF PERIODONTAL TREATMENT. Ukrainian Dental Almanac, (2), 38-40. Retrieved from https://dental-almanac.org/index.php/journal/article/view/24
Section
THERAPEUTIC DENTISTRY